Oncology Nutrition Market, Size, Share 2021-2028
Added: (Fri Nov 19 2021)
Pressbox (Press Release) -
Market Overview
The Global Oncology Nutrition Market is expected to grow at a CAGR of 8.20% during the forecasting period (2020-2027).
Cancer-affected people have a direct impact on their natural appetite and to avoid the risk of suffering from any other disorders due to improper nutrition intake, they need to take a proper nutritious diet. Hence the demand for oncology nutrition in the global market has been rising.
A number of advancements in the domain of oncology have also led to the growth of the global market and has given rise to several forms of nutrition for cancer patients.
The Nutritional Oncology Research Institute (NORI) Program is one of the most effective programs designed as an alternative for the treatment of cancers. However, the high cost of cancer treatment such as 120,000 for four doses is hindering the oncology nutrition market.
Download free sample: https://www.datamintelligence.com/download-sample/oncology-nutrition-market
Market Growth and Trends
One of the recent trends in global Oncology Nutrition market is a shift from parenteral nutrition to enteral nutrition due to its lower cost and complications along with new improvement in materials & compositions.
The Global Oncology Nutrition market growth is driven by several factors such as the rising incidence of cancer and the growing quality of clinical research on nutritional interventions.
Market Size
The total number of cancer deaths was estimated to be approx. 9 million globally. Among those, some 1.71 million were deaths due to lung cancer.
In 2019, an estimated 64,690 people (47,650 men and 17,040 women) will develop head and neck cancer.
Market Segementation
by Product Type
Segmentation by Cancer Type
• Head and Neck Cancer
• Pancreatic Cancer
• Stomach and Gastrointestinal Cancer
• Liver Cancer
• Esophageal Cancer
• Breast Cancer
• Lung Cancer
• Blood Cancer
• Others
Geographical Analysis
The market is segmented geographically into North America, South America, Europe, Asia-Pacific, and RoW. North America dominates the global Oncology Nutrition market due to the rising prevalence of chronic diseases & disorders, growing elderly population, and increasing healthcare expenditure in this region. United States health spending is projected to rise by 5.3% in 2018, due to rising prices of medical goods and services and higher Medicaid costs.
Competitive Analysis
The major players in the oncology nutrition market are Abbott Laboratories, Nestle S.A., Danone, Fresenius Kabi AG, and B. Braun Melsungen AG.
In July 2017, Enterome and Nestle Health Science formed a new company to develop microbiome diagnostics for multiple indications including inflammatory bowel disease (IBD) and liver disorders.
The report covers the factors impacting the market, Market Share Analysis, Price trend analysis, Product Benchmarking, and company profiles.
View Full Report: https://www.datamintelligence.com/research-report/oncology-nutrition-market
Enquiry Before Buying: https://www.datamintelligence.com/enquiry/oncology-nutrition-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at DataM Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com